Welcome to medications.com

Results: DNA was collected from 252 participants: 69% were white,...

Posted at 11:38 AM on Jun 03, 2008 by concernedcitizen, #31060
Results: DNA was collected from 252 participants: 69% were white, 26% were African American. Twenty-eight SNPs in the ALOX5, LTA4H, LTC4S, MRP1, and cysLT1R genes, and an ALOX5 repeat polymorphism were successfully typed. There were racial disparities in allele frequencies in 17 SNPs and in the repeat polymorphism. Association analyses were performed in 61 whites. Associations were found between genotypes of SNPs in the ALOX5 (rs2115819) and MRP1 (rs119774) genes and changes in FEV1 (p < 0.05), and between two SNPs in LTC4S (rs730012) and in LTA4H (rs2660845) genes for exacerbation rates. Mutant ALOX5 repeat polymorphism was associated with decreased exacerbation rates. There was strong linkage disequilibrium between ALOX5 SNPs. Associations between ALOX5 haplotypes and risk of exacerbations were found. Conclusions: Genetic variation in leukotriene pathway candidate genes contributes to variability in montelukast response. http://ajrccm.atsjournals.org/cgi/content/full/173/4/379
REPLY TO THIS POSTING | Private Message me | Add as friend | Flag as inappropriate
 
Reply 6 months ago on Jun 03, 2008 by dtrzaski, #8859

That conclusion says it all.

Private Message me | Add as friend | Flag as inappropriate
 
Reply 6 months ago on Jun 03, 2008 by concernedcitizen, #8860

Here is a 2008 study from Spain - smaller but same conclusions.

http://www.ncbi.nlm.nih.gov/pubmed/18339529

Private Message me | Add as friend | Flag as inappropriate

Make a reply to this posting:

Type your reply to this side effect post:




Medical advice disclaimer
© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com